LSA
VYGR icon

Leonteq Securities AG’s Voyager Therapeutics VYGR Stock Holding History

Leonteq Securities AG’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,000
Closed -$5.91K – 1349
2022
Q2 		$5.91K Sell
1,000
-2,000
-67% -$13.5K ﹤0.01% 1138
2022
Q1 		$22.9K Sell
3,000
-2,000
-40% -$8.92K ﹤0.01% 991
2021
Q4 		$13.6K Buy
+5,000
New +$17.1K ﹤0.01% 1126

Other funds holding VYGR

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Leonteq Securities AG's VYGR Position: Q3 2022 in Review

Leonteq Securities AG sold out of Voyager Therapeutics (VYGR) in Q3 2022, closing a stake of 1,000 shares — an estimated $5.91K sold.

Leonteq Securities AG first reported a position in VYGR in Q4 2021 and held it in 3 quarters. The position peaked at $22.9K in Q1 2022. 69 funds tracked by Wall St. Rank hold VYGR as of Q3 2022.

  • Leonteq Securities AG reported no remaining Voyager Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Leonteq Securities AG sold 1,000 Voyager Therapeutics shares in Q3 2022, an estimated $5.91K.
  • Leonteq Securities AG first reported a position in Voyager Therapeutics in Q4 2021 and held it in 3 quarters.
  • Leonteq Securities AG's Voyager Therapeutics position peaked at $22.9K in Q1 2022.
  • 69 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2022.

Based on Leonteq Securities AG's 13F filing for Q3 2022, filed 26 Mar 2026.